Viser 101 - 103 av 103 resultater
Tid Selskap Tittel Sektor Kategori
15 Mar 2023
14:25 CET
ARGENX SE argenx Announces UK MHRA Approval of VYVGART for the Treatment of Generalized Myasthenia Gravis 20103010 Biotechnology Other subject
02 Mar 2023
07:00 CET
ARGENX SE argenx Reports Full Year 2022 Financial Results and Provides Fourth Quarter Business Update 20103010 Biotechnology Other subject
02 Mar 2023
07:00 CET
ARGENX SE argenx Announces Planned Transition of Chief Operating Officer 20103010 Biotechnology Other subject